Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

InDex Pharmaceuticals Holding AB (FLERIE)

Stockholm
Currency in SEK
Disclaimer
0.5140
-0.0360(-6.55%)
Closed
FLERIE Scorecard
Unusual trading volume
Fair Value
Day's Range
0.51400.5360
52 wk Range
0.19800.9260
Bid/Ask
0.514 / 0.514
Prev. Close
0.55
Open
0.522
Day's Range
0.514-0.536
52 wk Range
0.198-0.926
Volume
29,702,112
Average Volume (3m)
5,854,031
1-Year Change
-6.55%
Shares Outstanding
532,687,650
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about FLERIE?
Vote to see community's results!
or

InDex Pharmaceuticals Holding AB Company Profile

As of June 10, 2024, Flerie AB was acquired by Flerie Invest AB., in a reverse merger transaction. Flerie AB engages in the research and development of pharmaceuticals for immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.

Employees
4
Market
Sweden
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.